Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Federico

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
Hepatology (Baltimore, Md.)|November 2, 2023
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statementsGennaro D'Amico, Alexander Zipprich, Càndid Villanueva, et al.
United European Gastroenterology Journal|November 30, 2023
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohortLoreta A Kondili, Alberto Zanetto, Maria Giovanna Quaranta, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2025
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian StudyCristina Della Corte, Daphne D'Amato, Adele Rocchetti, et al.
Journal of Hepatology|August 1, 2021
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiologyGennaro D'Amico, Luigi Maruzzelli, Aldo Airoldi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 15, 2018
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?Loreta A Kondili, Sarah Robbins, Sarah Blach, et al.
Lancet (London, England)|June 5, 2018
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trialPaolo Caraceni, Oliviero Riggio, Paolo Angeli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 14, 2024
Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of CholestasisVincenza Calvaruso, Ciro Celsa, Laura Cristoferi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2025
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World DatabaseAlessandro Loglio, Ivan Gardini, Massimiliano Conforti, et al.
Journal of Hepatology|January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosisElisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 29, 2025
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian ParadigmGian Paolo Caviglia, Eleonora Dileo, Antonella Olivero, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Hepatology (Baltimore, Md.)|November 2, 2023
Further decompensation in cirrhosis: Results of a large multicenter cohort study supporting Baveno VII statementsGennaro D'Amico, Alexander Zipprich, Càndid Villanueva, et al.
United European Gastroenterology Journal|November 30, 2023
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohortLoreta A Kondili, Alberto Zanetto, Maria Giovanna Quaranta, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2025
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian StudyCristina Della Corte, Daphne D'Amato, Adele Rocchetti, et al.
Journal of Hepatology|August 1, 2021
Performance of the model for end-stage liver disease score for mortality prediction and the potential role of etiologyGennaro D'Amico, Luigi Maruzzelli, Aldo Airoldi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 15, 2018
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals?Loreta A Kondili, Sarah Robbins, Sarah Blach, et al.
Lancet (London, England)|June 5, 2018
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trialPaolo Caraceni, Oliviero Riggio, Paolo Angeli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 14, 2024
Noninvasive Assessment of portal Hypertension in Patients With Primary Biliary Cholangitis is Affected by Severity of CholestasisVincenza Calvaruso, Ciro Celsa, Laura Cristoferi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 4, 2025
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World DatabaseAlessandro Loglio, Ivan Gardini, Massimiliano Conforti, et al.
Journal of Hepatology|January 10, 2025
Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosisElisabetta Degasperi, Maria Paola Anolli, Mathias Jachs, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 29, 2025
The Medical Impact of Hepatitis D Virus Infection in Natives and Immigrants: The Italian ParadigmGian Paolo Caviglia, Eleonora Dileo, Antonella Olivero, et al.
Pageof 20